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A B S T R A C T
The type of pain after laparoscopic surgery differs considerably from that seen after laparotomy. Whereas laparotomy
results mostly in parietal pain, patients after laparoscopic cholecystectomy complain more of visceral pain results from
the stretching of intraabdominal cavity, peritoneal inflammation and phrenic nerve irritation caused by residual carbon
dioxide in the peritoneal cavity. Intraperitoneal (IP) administration of some drugs can be effective for pain relief after
laparoscopic surgery. The purpose of this study was to asses the effects of intraperitoneal application of bupivacaine or
bupivacaine in combination with tramadol on pain relief after laparoscopic cholecystectomy. After informed written con-
sent and local ethic committee approval, ninthy patients of ASA I and II grade undergoing elective laparoscopic cho-
lecystectomy for cholelythiasis were recruited in the study. At the end of laparoscopic cholecystectomy 30 patients in each
group received 50 mL saline 0.9% (group C), bupivacaine 0.25% (group B) or bupivacaine 0.25% with tramadol 100 mg
(group T). VAS pain was estimated at 30 minutes, 1, 2, 4 and 24 hours after surgery. Postoperative analgesic requires
were also assessed. Pain scores were significantly lower in group receiving the IP bupivacaine with tramadol and bu-
pivacaine compared to saline group. Intraperitoneal applications of these drugs reduced consumption of supplementary
postoperative analgesic medication. Intraperitoneal administration of bupivacaine with tramadol and bupivacaine are
simple to use and effective in a reduction of pain after laparoscopic cholecystectomy. In our study we found no differences
between bupivacaine with tramadol and bupivacaine in postoperative VAS score and analgesic requirements.
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Introduction
Laparoscopic cholecystectomy results in less pain com-
pared to open cholecystectomy, but pain still exist in
most of the patients and they often require postoperative
opioid treatement.
The type of pain after laparoscopic surgery differs
considerably from that seen after laparotomy. Whereas
laparotomy results mostly in parietal pain, patients after
laparoscopic cholecystectomy complain more of visceral
pain results from the stretching of intraabdominal cav-
ity, peritoneal inflammation and phrenic nerve irritation
caused by residual carbon dioxide in the peritoneal cavity1.
Some investigators have asserted that intraperitoneal
administration of local anesthetics and opioids2–8 is effec-
tive method of reducing the pain. However other investi-
gators did not find any analgesic efficacy of IP adminis-
tration of local anesthetics9–11. There is few data in litera-
ture on analgesic effect of intraperitoneal administration
of local anaesthetics in combination with opioid for lap-
aroscopic cholecystetctomy4,5,12.
Laparoscopic cholecystectomy is commonly perfor-
med procedure for treating symptomatic gallstones. This
study was designed to examine the efficacy of itraperi-
toneal administartion of tramadol, as weak opioid, with
bupivacaine, long-lasting local anesthetic, for pain relief
after laparoscopic cholecystectomy.
Patients and Methods
After informed written consent and local ethic com-
mittee approval, ninthy patients of ASA I and II grade
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undergoing elective laparoscopic cholecystectomy for
cholelythiasis were recruited in the study. Any patient
with contraindications to tramadol or bupivacaine was
excluded from the study. Patients were also excluded if
there were complications during operation or the opera-
tion had to be converted to an open cholecystectomy.
Standard operative method was used as described13. A
questionnaire was completed for each patient, giving de-
mographic, perioperative and postoperative details.
This was prospective, randomized, double-blinded study
with 30 patients in each group.
All patients received same anesthetic technique. They
were premedicated with midazolam (7.5 mg orally) 30
minutes before surgery. General anesthesia was induced
by intravenously administration of sufentanil (0.15–0.3
mg/kg), propofol (2.5–3 mg/kg) and rocuronium (0.6 mg/kg)
and was maintained with a mixture of 1.5–2 vol % iso-
flurane, oxygen and air. Minute ventilation was adjusted
to keep end-tidal pCO2 at 4.5–5.5 kPa.
At the end of the surgery, the patients allocated to
Group C received 50 mL of saline, those allocated in
group B received 50 mL of 0.25% bupivacaine and pa-
tients allocated in group T received 50 mL of bupivacaine
0.25% with 100 mg of tramadol into the hepatodiaphrag-
matic space, near and above the hepato-duodenal liga-
ment and above the gall bladder bed under direct vision.
The test solution were drawn into the coded syringes and
given to surgeons who did not know their content.
After surgery all patients stayed in PACU for two
hours. In PACU postoperative pain was assessed using
100 mm visual analog scale (VAS). VAS was recorded at
admission, 0.5, 1 and 2 hours after admission. Supple-
mental analgesic medication was available upon request
and was recorded at the above intervals. In PACU intra-
venous nonsteroidal anti-inflammatory analgesic (NSAID;
diclofenac, 75 mg i. v.) were used for pain scores less than
3 and opioids (pethidine 1 mg/kg i.m.) for pain scores
above 3. The drugs were administrated on demand by an
experienced recovery nurse with no knowledge of perio-
perative analgesia administration.
All enrolled patients completed the study. Results are
expressed as mean ± SD. Data were analyzed by two-way
analysis of variance. Demographic data were studied us-
ing Student’s t-test. Pain score were compared using the
Kruscal-Wallis and Mann-Whitney U-test. Results were
considered to be statistically significant at the 5% critical
level (p<0.05). Data were analyzed with statistical pro-
gram Statistica for Windows version 7.1 (StatSoft Inc,
Tulsa, USA).
Results
Ninety patients completed the study. There were no
significant differences in patients’ demographics data
(Table 1). Supplementary postoperative analgesic con-
sumption was compared between groups (Table 1). Ac-
cording to postoperative VAS pain score in PACU NSAIDs
or opoioides were administrated. Twenty eight patients
in group C received NSAID as supplementary analgesic
medication while in group T five and in group B seven
patient requested same drugs (Table 1). Twenty six pa-
tients in group C received opioid analgesia after surgery
while in group B and group T no one received opioids
(p<0.05) (Table 1).
Statistically significant differences (p<0.05) were found
in pain intensity between group C and T and group C and
B 30 minutes, 1, 2 and 4 hours after surgery (Figure 1).
We found no statistically significant difference in pain
scores between group B and group T. At 24 postoperative
hour’s pain were reduced significantly in all groups
(Figure 1).
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TABLE 1
PRESENTATION OF DEMOGRAPHIC CHARACTERISTICS AND SUPPLEMENTARY POSTOPERATIVE MEDICATIONS
Group C (n=30) Group B (n=30) Group T (n=30)
Sex ratio (F:M) 18:12 20:10 17:13
Agea (years) 54.6 ± 11.1 51.1 ± 12 56.1 ± 12
Body weighta (kg) 74.8 ± 11.5 77.2 ± 12 76.2 ± 12
Duration of operationa (min) 75.2 ± 22 78.8 ± 19 76.8 ± 17.5
Supplementary postoperative medication (number of patients)
NSAID 28* 7 5
opioids 26* 0 0
F – female, M – male, NSAID – nonsteroidal anti-inflammatory drugs, a – mean ± SD, * – p<0.05






























Fig 1. The effect of intraperitoneal bupivacaine and bupivacine
with tramadol on pain using visual analog scale (VAS) at 0.5, 1,
2, 4 and 24 hours after surgery. Values are mean ± SD. *p<0.05
was considered statistically significant.
Discussion
We found that IP administration of bupivacaine with
tramadol as well as bupivaciane have same potency to re-
duce postoperative pain during first four hours after lap-
aroscopic cholescystectomy. In general the intensity of
pain was miled to moderate. A controversy exists over
the effectiveness and clinical value of intraperitoneal lo-
cal anesthetics or opioids treating pain after laparoscopic
cholecystectomy. The reason for these variations in re-
sult could be differences in the high variable study pro-
tocols4,12.
Over a decade there have been controversy data about
analgesic benefit of bupivacaine administrated intraperi-
toneally after laparoscopic cholecystectomy. Some in-
vestigators3,6–8 found that IP bupivacaine was effective in
pain reduction, while others9,10 showed that it did not at-
tenuate pain following laparoscopic surgery. The reasons
for these variations in result is not known, but the time
of injection, site of injection, as well as concentration of
local anesthetics could play important role4,5,8,14. In our
study we found that IP bupivacaine is effective in pain
control during early postoperative period after laparo-
scopic cholecystectomy.
Our work also highlights the analgesic effect of intra-
peritoneally administrated bupivacaine with tramadol
after laparoscopic cholecystectomy. As bupivacaine, which
in our and some other studies3,6–8,14 reduce pain after lap-
aroscopic cholecystectomy, we found that bupivacaine
with tramadol to be as well effective after laparoscopic
cholecystectomy.
Memis et al.15,16 showed that intraperitoneal adminis-
tration of bupivacaine with tramadol and bupivacaine is
very effective in the early postoperative period in pa-
tients undergoing laparoscopic tube ligation and in total
abdominal histeroctomy.
Tramadols analgesic effect can be explained by its
dual mechanism of action where it blocks the reuptake of
norepinephrine and 5-hydroxytryptamine at the á2 adre-
nergic receptor level17. Its mode of action is though to be
dorsal horn of spinal cord or in the brain. Tramadol could
also have a local effect when given intraperitoneally after
laparoscopic surgery, which adds to the effect from sys-
temic uptake and action in central nervous system.
Conclusion
In our study we found no differences between bupi-
vacaine with tramadol and bupivacaine in postoperative
VAS score and analgesic requirements.
Application of bupivacaine with tramadol and bupi-
vacaine intraperitoneally attenuated pain after laparo-
scopic cholecystectomy. Addition of tramadol to local an-
aesthetics for intraperitoneal analgesia merit further study
in patients undergoing laparoscopic cholesystectomy.
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INTRAPERITONEALNA ANALGEZIJA KOD LAPAROSKOPSKE KOLECISTEKTOMIJE:
BUPIVAKAIN NASPRAM BUPIVAKAINA S TRAMADOLOM
S A @ E T A K
Bol nakon laparoskopske kolecistektomije zna~ajno se razlikuje od boli nakon laparotomije. Dok kod laparotomije
prevladava parijetalna bol bolesnici nakon laparoskopske kolecistektomije `ale se na visceralnu bol. Svrha ove studije
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bila je procjena u~inkovitosti IP aplikacije bupivakaina ili bupivakaina u kombinaciji sa tramadolom na bol nakon
laparoskopske kolecistektomije. U studiju je uklju~eno 90 bolesnika predvi|enih za elektivnu laparoskopsku kolecis-
tektomiju. Na kraju laparoskopske kolecistektomije kod 30 bolesnika iz svake grupe IP je aplicirano po 50 mL: fiziolo-
{ke otopine (grupa C), bupivakain 0,25% (grupa B) ili bupivakain 0,25% sa 100 mg tramadola (grupa T). Procjena boli
putem vizualne ocjenske ljestvice (VAS score) bilje`ila se nakon 30 minuta 1, 2, 4 i 24 sata nakon operativnog zahvata.
Postoperativna analgetska potra`ivanja su tako|er bilje`ena. Intenzitet boli bio je zna~ajno manji u grupi koja je IP
dobila bupivakain s tramadolom ili bupivakain u odnosu na grupu koja je dobila fiziolo{ku otopinu. IP aplikacijom
bupivakaina samog ili u kombinaciji sa tramadolom zna~ajno se smanjila postoperativna analgetska potra`nja. U na{oj
studiji nije na|ena statisti~ki zna~ajna razlika izmedju IP aplikacija bupivakaina sa tramadolom i bupivakaina glede
postoperativne procjene boli i analgetskih potra`ivanja.
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